PFE vs. BMY, ZTS, ABBV, MRK, JNJ, ABT, SNY, VRTX, NVS, and REGN
Should you be buying Pfizer stock or one of its competitors? The main competitors of Pfizer include Bristol-Myers Squibb (BMY), Zoetis (ZTS), AbbVie (ABBV), Merck & Co., Inc. (MRK), Johnson & Johnson (JNJ), Abbott Laboratories (ABT), Sanofi (SNY), Vertex Pharmaceuticals (VRTX), Novartis (NVS), and Regeneron Pharmaceuticals (REGN). These companies are all part of the "pharmaceutical preparations" industry.
Bristol-Myers Squibb (NYSE:BMY) and Pfizer (NYSE:PFE) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings, community ranking and dividends.
Bristol-Myers Squibb presently has a consensus price target of $60.00, suggesting a potential upside of 36.02%. Pfizer has a consensus price target of $35.86, suggesting a potential upside of 23.94%. Given Pfizer's higher probable upside, research analysts clearly believe Bristol-Myers Squibb is more favorable than Pfizer.
Bristol-Myers Squibb pays an annual dividend of $2.40 per share and has a dividend yield of 5.4%. Pfizer pays an annual dividend of $1.68 per share and has a dividend yield of 5.8%. Bristol-Myers Squibb pays out -77.4% of its earnings in the form of a dividend. Pfizer pays out -2,799.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Bristol-Myers Squibb has increased its dividend for 16 consecutive years and Pfizer has increased its dividend for 15 consecutive years. Pfizer is clearly the better dividend stock, given its higher yield and lower payout ratio.
In the previous week, Bristol-Myers Squibb had 6 more articles in the media than Pfizer. MarketBeat recorded 43 mentions for Bristol-Myers Squibb and 37 mentions for Pfizer. Pfizer's average media sentiment score of 0.58 beat Bristol-Myers Squibb's score of 0.36 indicating that Bristol-Myers Squibb is being referred to more favorably in the media.
76.4% of Bristol-Myers Squibb shares are owned by institutional investors. Comparatively, 68.4% of Pfizer shares are owned by institutional investors. 0.1% of Bristol-Myers Squibb shares are owned by company insiders. Comparatively, 0.1% of Pfizer shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Bristol-Myers Squibb has higher earnings, but lower revenue than Pfizer. Pfizer is trading at a lower price-to-earnings ratio than Bristol-Myers Squibb, indicating that it is currently the more affordable of the two stocks.
Pfizer has a net margin of -0.56% compared to Pfizer's net margin of -13.50%. Pfizer's return on equity of 8.83% beat Bristol-Myers Squibb's return on equity.
Bristol-Myers Squibb has a beta of 0.45, indicating that its share price is 55% less volatile than the S&P 500. Comparatively, Pfizer has a beta of 0.63, indicating that its share price is 37% less volatile than the S&P 500.
Pfizer received 411 more outperform votes than Bristol-Myers Squibb when rated by MarketBeat users. Likewise, 69.06% of users gave Pfizer an outperform vote while only 66.87% of users gave Bristol-Myers Squibb an outperform vote.
Summary
Pfizer beats Bristol-Myers Squibb on 12 of the 21 factors compared between the two stocks.
Get Pfizer News Delivered to You Automatically
Sign up to receive the latest news and ratings for PFE and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PFE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
